Literature DB >> 33216283

The Neuroprotective Effect of Mesna on Cisplatin-Induced Neurotoxicity: Behavioral, Electrophysiological, and Molecular Studies.

Somayeh Noroozzadeh1, Hedieh Esmaeili1, Hakimeh Saadati2,3, Keyvan Amirshahrokhi4, Javad Shadman2,3, Ali Niapour5.   

Abstract

Peripheral neuropathy and cognitive impairments following cisplatin administration may interfere with the clinical usage of the drug. Mesna is a chemoprotective agent with anti-inflammatory and anti-oxidant effects. Our study aimed to investigate the protective effects of mesna against cisplatin-induced neurotoxicity. Neurotoxicity was induced by the administration of 2.5 mg/kg cisplatin twice a week for four consecutive weeks in male Wistar rats. The neuroprotective effect of mesna (150 mg/kg/day) was evaluated through behavioral, electrophysiological, and molecular studies. Cisplatin treatment caused passive avoidance memory impairment, increased anxiety-like behaviors, altered thermal sensitivity, and decreased muscle strength in a grip strength test. Our electrophysiological studies indicated that administration of cisplatin induced peripheral sensory neuropathy and decreased the amplitudes of the compound action potential of sensory nerves. Cisplatin administration increased MDA and 4-HNE levels and decreased anti-oxidant (SOD and GPx) enzymes. Proinflammatory cytokines (IL-1β and TNF-α) and metalloproteinase-2 and 9 (MMP-2/9) were increased by cisplatin treatment. Morphological alterations were observed in the dorsal root ganglion (DRG) of cisplatin-treated rats. Cognitive impairments, anxiety, muscle strength, and thermal sensitivity changes induced by cisplatin were improved with mesna treatment. The reduced conduction velocity in sensory nerves was recovered in the cisplatin + mesna group. Mesna partially alleviated redox imbalance, reduced the proinflammatory cytokines, and MMP-2/9 levels. Mesna administration also relieved the morphological changes in DRG of cisplatin-treated rats. In conclusion, our results revealed that mesna can alleviate cisplatin-induced central and peripheral nervous system toxicity. These results support the concept that chemotherapy-induced neuropathy can be partially inhibited via mesna.

Entities:  

Keywords:  Cisplatin-induced neuropathy; Dorsal root ganglion; Inflammation; Mesna; Nerve conduction velocity; Oxidative stress

Year:  2020        PMID: 33216283     DOI: 10.1007/s12640-020-00315-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  43 in total

Review 1.  Morphological and functional diversity of first-order somatosensory neurons.

Authors:  Eder Ricardo de Moraes; Christopher Kushmerick; Lígia Araujo Naves
Journal:  Biophys Rev       Date:  2017-09-09

Review 2.  Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?

Authors:  V A Carozzi; A Canta; A Chiorazzi
Journal:  Neurosci Lett       Date:  2014-10-22       Impact factor: 3.046

3.  Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes.

Authors:  Abdullah Al Maruf; Peter J O'Brien; Parvaneh Naserzadeh; Rozhina Fathian; Ahmad Salimi; Jalal Pourahmad
Journal:  Drug Chem Toxicol       Date:  2017-03-16       Impact factor: 3.356

4.  Gastroprotective effect of 2-mercaptoethane sulfonate against acute gastric mucosal damage induced by ethanol.

Authors:  Keyvan Amirshahrokhi; Ali-Reza Khalili
Journal:  Int Immunopharmacol       Date:  2016-03-09       Impact factor: 4.932

5.  Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.

Authors:  Noelle Callizot; Emile Andriambeloson; Jonathan Glass; Michel Revel; Pamela Ferro; Rocco Cirillo; Pierre-Alain Vitte; Michel Dreano
Journal:  Cancer Chemother Pharmacol       Date:  2008-02-13       Impact factor: 3.333

6.  Nociceptors are interleukin-1beta sensors.

Authors:  Alexander M Binshtok; Haibin Wang; Katharina Zimmermann; Fumimasa Amaya; Daniel Vardeh; Lin Shi; Gary J Brenner; Ru-Rong Ji; Bruce P Bean; Clifford J Woolf; Tarek A Samad
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

7.  Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy.

Authors:  Juan P Cata; Han-Rong Weng; Patrick M Dougherty
Journal:  Brain Res       Date:  2008-07-15       Impact factor: 3.252

8.  Mitigation of cisplatin-induced peripheral neuropathy by canagliflozin in rats.

Authors:  Ahmed A Abdelsameea; Soad L Kabil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-03       Impact factor: 3.000

9.  Curcumin Ameliorates Functional and Structural Abnormalities in Cisplatin-induced Neuropathy.

Authors:  Sithiporn Agthong; Athitaya Kaewsema; Thuntawat Charoensub
Journal:  Exp Neurobiol       Date:  2015-04-27       Impact factor: 3.261

10.  Paclitaxel-induced peripheral neuropathy is caused by epidermal ROS and mitochondrial damage through conserved MMP-13 activation.

Authors:  Anthony M Cirrincione; Adriana D Pellegrini; Jessica R Dominy; Marisa E Benjamin; Irina Utkina-Sosunova; Francesco Lotti; Stanislava Jergova; Jacqueline Sagen; Sandra Rieger
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

View more
  1 in total

1.  Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity.

Authors:  Ghadha Ibrahim Fouad; Sara A M El-Sayed; Mostafa Mabrouk; Kawkab A Ahmed; Hanan H Beherei
Journal:  Neurotox Res       Date:  2022-08-15       Impact factor: 3.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.